Infusion Pumps Market Assessment, By Product Type [Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other

Infusion Pumps Market Assessment, By Product Type [Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Others], By Application Type [Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others], By Technology [Traditional Infusion Pump, Specialty Infusion Pump], By End-user [Hospitals, Ambulatory Care Settings, Home-Care Settings, Academic & Research Institutes], By Region, Opportunities and Forecast, 2017-2031F

Global infusion pumps market is projected to witness a CAGR of 5.97% during the forecast period 2024-2031, growing from USD 12.17 billion in 2023 to USD 19.35 billion in 2031. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Infusion pumps and accessories are medical devices that are used to administer any fluid, medication, or nutrients to the patient’s body through their vein (intravenously), under their skin (subcutaneously), or near their spinal cord (epidurally). These devices are very important, as they play a very critical role in delivering precise and controlled amounts of doses to the patient’s bloodstream or body while also ensuring the most effective treatment.

The infusion pumps market is expected to grow rapidly due to factors such as the rising prevalence of chronic diseases, technological advancements in the healthcare sector, strategic initiatives such as mergers and acquisitions, and the rise in expenditure made on R&D by healthcare device companies. Shanghai MicroPort Lifesciences Co., Ltd. developed a chemotherapy infusion pump called AutoEx, which received its marketing approval in March 2022 from China’s National Medical Product Administration. AutoEx includes a motor unit and a reusable infusion pump. The system eliminates the hassle of cleaning manually. These saves time as well as helps medical organizations conserve their nursing resources. It is useful in administering the drug safely and reliably while taking care of the patient’s comfort as well.

Technological Advancements

Infusion pumps and accessories have greatly benefited from technological improvements that have improved patient care, increased safety, and streamlined healthcare processes. Advanced features, including touch-screen interfaces, wireless networking, and integration with electronic health records (EHRs), are all part of smart infusion pumps. In addition, they can compute, monitor in real time, and notify healthcare practitioners when prescribed drug schedules are not being followed. Dosing recommendations and safety checks for drugs are included in many infusion pumps currently in the market. By verifying that the recommended prescription and dosage are accurate, these libraries aid in the prevention of medication errors. Infusion pumps can connect wirelessly to various healthcare systems, including pharmacy and EHR systems. This facilitates automatic infusion data documentation, remote monitoring, and smooth data interchange. Medication mistakes can be decreased by using barcode scanning to validate patient information and medications. To verify the right drug and dosage, healthcare professionals can scan the barcodes on patient wristbands and prescription containers. A function called Dose Error Reduction Systems (DERS) notifies medical professionals if the recommended dosage of a medicine exceeds acceptable bounds by comparing it to predetermined safety limits.

By reducing the chance of overdosing or underdosing, this improves patient safety. Healthcare providers can remotely monitor infusion pumps to follow the progress of infusions and take action in the event of any problems or alarms. Particularly in home healthcare settings, this is beneficial. Certain infusion pumps can be used with smartphone apps that let users track their treatment, get alerts, and connect with medical professionals. Patient adherence and engagement can both be enhanced by these applications. Infusion pumps can store and carry out complex dose schedules and other personalized treatment plans. Improvements in battery technology have resulted in extended battery life for portable infusion pumps, guaranteeing patients uninterrupted medication delivery. Patients now have more mobility during therapy due to the miniaturization of infusion pumps, making them more convenient to use and easily portable.

In June 2023, B. Braun Medical Inc. announced the launch of its latest next-generation infusion management software, called DoseTrac Enterprise Infusion Management Software. This software allows organizations to receive a mix of real-time views and retrospective reporting features, which also help them better understand their infusion pump fleet and associated data. DoseTrac also allows connectivity of up to 40,000 pumps together using just one application.

Increasing Use of Infusion Pumps in Ambulatory Settings

The need for infusion pumps and accessories is being primarily driven by increasing usage in ambulatory settings. Many medical operations and treatments that once required the patient to be hospitalized can be completed in outpatient settings. This covers a range of infusion treatments, including biologics, antibiotics, and chemotherapy because it allows them to continue with their everyday routines and reduces the expense and inconvenience of hospital stays, patients prefer receiving treatment in these settings. Home infusion therapy has become very common, allowing patients to receive intravenous drugs or fluids at the convenience of their own homes.

Infusion pumps are essential for precise and regulated drug administration, which is again essential in home-based care. Home infusion is typically beneficial for patients with long-term medical issues such as diabetes, autoimmune disorders, or infections. Home healthcare and other ambulatory settings provide patients with a cozier and more familiar environment. Patients can receive their treatments using infusion pumps while still being in familiar surroundings, which has a good effect on their general health and compliance with treatment plans. Hospitalization is typically more expensive than ambulatory care settings. Its cost-effectiveness is appealing to healthcare professionals as well as patients. In these situations, using infusion pumps can help control expenses without sacrificing treatment quality. Patients who reside in rural areas or have limited mobility benefit from improved healthcare accessibility in ambulatory settings, particularly in home-based care. These patients can receive the required therapies without having to visit the hospital frequently. Hospitals can focus more effectively on critical cases and lessen the strain on inpatient facilities by transferring some infusion therapy to ambulatory settings. This enhances the management of the healthcare system.

Specialized care, such as infusion therapy for diseases including multiple sclerosis, Crohn's disease, and rheumatoid arthritis, is frequently offered in ambulatory settings. Patients are empowered to actively participate in their own health management in ambulatory settings, especially in home healthcare. In addition to having more influence over their treatment plans, patients are trained to operate infusion pumps. Technological developments in healthcare, such as telemedicine and remote monitoring, have simplified the management of patients undergoing infusion therapy in outpatient settings. Doctors can keep an eye on their patients' progress from a distance and take appropriate action when needed. Eitan Medical recently launched its new multi-therapy ambulatory infusion system, which is designed to enhance post-acute care. The name of this multi-therapy ambulatory infusion system is Avoset, and it can remotely monitor infusion therapy data to facilitate a better patient care experience.

Volumetric Infusion Pumps Segment Leads the Market

Parenteral feeding and illness treatment are two areas in which volumetric infusion pumps have extensive use. The strong demand for volumetric infusion pumps can be attributed to their safety, accuracy, and simplicity in treating numerous therapeutic areas. The market for volumetric infusion pumps is anticipated to grow significantly because of an increase in medicine and blood transfusion cases, as well as an increase in targeted product launches by major players. Over the course of the study period, the segment is likely to grow as a result of the rising need for drug infusions brought on by an increase in injuries and trauma cases. According to the Road Safety Observatory report released in February 2022, police forces in France recorded 3,728 injury accidents in January 2022 — a higher number than in January 2021 (3,508).

Over the course of the forecast period, the increasing number of traffic accidents is expected to result in blood loss and the need for emergency transfusions, which will fuel the segment's expansion. Additionally, the development of novel volumetric pumps and the rise in regulatory approvals are anticipated to support the growth of this segment. Fresenius Kabi received regulatory approval from the FDA in March 2022 for its wireless infusion system called Agilia Connect. This system has Agilia volumetric pump and Agilia syringe pump connected together by a software suite called Vigilant Master Med Technology. These are the first devices to get approval by following TIR101 standards developed by the Association for the Advancement of Medical Instrumentation.

North America to Dominate the Infusion Pumps Market

Due to the rise in chronic illnesses, high healthcare costs, the growing number of surgeries performed to treat chronic illnesses, the increased investment in research and development, and the presence of major players in the region, North America is anticipated to hold a sizable market share in the infusion pumps and accessories market. Furthermore, since blood transfusions help the body produce healthy red blood cells, they are essential in the treatment of cancer. Furthermore, internal bleeding is a side effect of several cancers, especially those affecting the digestive system, which exacerbates anemia and the patient's condition. Thus, it is anticipated that infusion pumps and associated accessories will be used in a significant percentage of cancer cases.

For example, the Canadian Cancer Society's 2022 figures show that around 233,900 cancer cases were diagnosed in Canada in 2022. This shows that the high burden of cancer cases contribute significantly to the overall growth of the infusion pumps market in the coming years. Moreover, strategic initiatives by major competitors, like partnerships, joint ventures, and product launches in the North American market, should support market expansion throughout the projection period. Medtronic introduced an extended infusion set in November 2022, which was among the first infusion sets approved for use for up to seven days in the US. The Medtronic Extended infusion set doubles the wear time of an infusion set by utilizing advanced materials that help prevent insulin preservative loss and maintain insulin flow and stability.

Future Market Scenario (2024-2031F)

The market growth of infusion pumps is steadily increasing due to a variety of factors. This market is expected to grow further majorly because of how important the involvement of fusion pumps in any treatment. Innovations in technology is another factor that is attracting investors and tech-giants to invest money in it. Mandaya Royal Hospital, which is ranked the best private hospital in Indonesia and most comprehensive cancer hospital, is equipped with a variety of advanced technologies, many of which are unique and the first of their kind in Indonesia. Their latest addition has been the Terufusion Smart Infusion Pump, which is the most advanced radiotherapy equipment from Elekta, used for treatment of breast cancer and tumour mapping. This smart pump can also track the amount of fluid delivered to the patient.

Key Players Landscape and Outlook

Several companies such as Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic PLC, Baxter International Inc., Fresenius Kabi AG, Boston Scientific Corporation, Shenzhen Mindray Bio-Medical Electronics Co Ltd, ICU Medical Inc.., Moog Inc., Terumo Corporation, etc., are expanding business by planning and adopting new strategies. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few strategies through which the companies are trying to achieve presence and market expansion.

In June 2023, LTS, a pharmaceutical technology firm that creates and produces drug delivery systems, acquired the wearable injectors division of Eitan Medical, a company that specializes in infusion therapy and drug delivery solutions. Selling the wearable injectors division was a strategic move that complemented Eitan Medical's focus on its main infusion treatment line.

Mindray introduced its BeneFusion ‘i’ Series and ‘u’ Series infusion systems in February 2023. These devices offer drug safety, adaptive customisation, and high precision in a range of therapeutic situations. The enhanced characteristics of the current generation of smart pumps reduce pharmaceutical errors, speed up workflow, and increase cost-effectiveness, making them useful in endoscopy, obstetrics, cancer, emergency rooms, and other disciplines.